Request a demo
Request a demo

Improving the efficiency of multidisciplinary teams

Learn how you can improve and standardize tumor boards across the entire organization and network.

Two prospective multi-year studies reveal how navify Tumor Board impacts multidisciplinary team meetings.
Download the results

Improving the efficiency of multidisciplinary teams

Learn how you can improve and standardize tumor boards across the entire organization and network.

Two prospective multi-year studies reveal how navify Tumor Board impacts multidisciplinary team meetings.
Download study results

navify Tumor Board improves workflow efficiency as proven in two significant multi-year prospective studies

Study results show continuous and sustained improvements over time

Standardizing care coordination

 
PreviousNext
123

Case preparation time

Case discussion time

Case postponement rate (ENT, TB)

REDUCTION IN
CASE POSTPONEMENT RATE

Ear, Nose and Throat tumor board case postponement rate from 1 in 5 cases to 1 in 10 cases.2

See the evidence behind navify Tumor Board

Download the studies summary sheet.

Download the
study results

Download now

Watch study authors discuss the results of two prospective multi-year studies

Two prospective multi-year studies reveal how navify Tumor Board impacts multidisciplinary team meetings, specifically case preparation, discussion time and postponement of cases. Authors Dr. Richard D. Hammer and Dr. Matthew Prime discuss how navify Tumor Board is delivering sustained benefits at the University of Missouri (MU) Ellis Fischel Cancer Center.

Explore
more

Value beyond tumor board

Read more

Cost effectiveness

Read more

References & notes

  1. Hammer R. D., et al. (2020) ‘Digital Tumor Board Solutions Have Significant Impact on Case Preparation’, JCO Clinical Cancer Informatics, 4(4), p757-768.
  2. Hammer, RD, Fowler D, Sheets L, Siadimas A, Guo C, Prime M. A digital tumor board solution impacts case discussion time and postponement of cases in tumor boards. Health and Technology 2021-02-27 DOI 10.1007/s12553-021-00533-x.

Interested in learning more?

Request a Demo

Interested in learning more?

Request a demo

Interested in learning more?

Request a demo
  • Improving patients’ experience
  • Reducing time to treatment
  • Improving clinical care coordination
  • Increasing patient engagement
  • Optimizing clinical decision-making
  • Managing the data avalanche
  • Rethinking multidisciplinary collaboration
  • Streamlining tumor board preparation
  • Supporting guidelines compliance
  • Building an intelligent lab
  • Differentiate from competitors & impact patient care
  • Improving the operational efficiency of your lab
  • Integrate data streams

Find us
Roche Information Solutions
Roche Molecular Systems, Inc.
2881 Scott Blvd
Santa Clara, CA 95050

  • Innovating healthcare IT
  • Open, interoperable ecosystem
  • Security & privacy
  • Integration & implementation
  • About us
  • Roche heritage
  • Vision & mission
  • News & events
  • Stories
  • Clinical evidence
  • Products
  • navify Oncology Hub
  • navify Tumor Board
  • navify Mutation Profiler
  • navify Mutation Caller
  • navify Digital Pathology
  • navify Pass
  • navify Sample Tracking

© Roche Molecular Systems, Inc.
NAVIFY is a trademark of Roche.
All other product names and trademarks are the property of their respective owners.
* Product in development and not commercially available

  • Terms & conditions
  • Privacy policy
  • Cookie policy
  • Cookie preferences
  • California supplemental privacy notice

Not all products of this product portfolio are intended or approved for diagnostic use. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

Scroll to top
×

You will be redirected to another site. Do you want to continue?

OK